Clinical Trials Browser

Phase 2 × Colonic Neoplasms × cabozantinib × Clear all

NCT04963283 2026-03-31

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06171854 2024-01-02

ABACO

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms